BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2033450)

  • 1. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study.
    Krischer JP; Ragab AH; Kun L; Kim TH; Laurent JP; Boyett JM; Cornell CJ; Link M; Luthy AR; Camitta B
    J Neurosurg; 1991 Jun; 74(6):905-9. PubMed ID: 2033450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report.
    Baram TZ; van Eys J; Dowell RE; Cangir A; Pack B; Bruner JM
    Cancer; 1987 Jul; 60(2):173-7. PubMed ID: 3594355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children.
    Ater JL; van Eys J; Woo SY; Moore B; Copeland DR; Bruner J
    J Neurooncol; 1997 May; 32(3):243-52. PubMed ID: 9049886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy.
    Hayani A; Mahoney DH; Taylor LD
    J Neurooncol; 1992 Sep; 14(1):57-62. PubMed ID: 1469465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.
    Evans AE; Jenkin RD; Sposto R; Ortega JA; Wilson CB; Wara W; Ertel IJ; Kramer S; Chang CH; Leikin SL
    J Neurosurg; 1990 Apr; 72(4):572-82. PubMed ID: 2319316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report.
    Kretschmar CS; Tarbell NJ; Kupsky W; Lavally BL; Loeffler JS; Wolfe L; Strand R; Scott RM; Sallan SE
    J Neurosurg; 1989 Dec; 71(6):820-5. PubMed ID: 2585072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
    Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
    Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy with MOPP and intrathecal methotrexate in children with brain tumors].
    Sato J; Ninomiya T; Saijo T; Akita H; Miki Y; Hirose M; Hashimoto T; Miyao M; Matsumoto K
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3266-70. PubMed ID: 3777962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma.
    Loeffler JS; Kretschmar CS; Sallan SE; LaVally BL; Winston KR; Fischer EG; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):177-81. PubMed ID: 3391815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).
    Tait DM; Thornton-Jones H; Bloom HJ; Lemerle J; Morris-Jones P
    Eur J Cancer; 1990 Apr; 26(4):464-9. PubMed ID: 2141512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOPP regimen as primary chemotherapy for brain tumors in infants.
    van Eys J; Cangir A; Coody D; Smith B
    J Neurooncol; 1985; 3(3):237-43. PubMed ID: 3840526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
    N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
    Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
    J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91.
    von Bueren AO; von Hoff K; Benesch M; Rutkowski S
    Klin Padiatr; 2009; 221(6):396-7. PubMed ID: 19890797
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone (NSC-10023) with or without nitrogen mustard (NSC-762)(MOPP vs OPP) in children with recurrent brain tumors.
    Cangir A; Ragab AH; Steuber P; Land VJ; Berry DH; Krischer JP
    Med Pediatr Oncol; 1984; 12(1):1-3. PubMed ID: 6546602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy with procarbazine, vincristine and prednisone for medulloblastomas. A preliminary report.
    Seiler RW; Bernasconi S; Berchtold W; Feldges A; Imbach P; Lüthi A; Plüss HJ; Vassella F; Wyss M; Wagner HP
    Helv Paediatr Acta; 1981 Jul; 36(3):249-54. PubMed ID: 7275674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose chemotherapy with stem-cell transplantation in a metastatic medulloblastoma in an adult: a case report and review of the literature.
    Cottu PH; Giacchetti S; Mignot L; Epardeau B; Visot B; Extra JM; Espie M; Marty M
    J Neurooncol; 1994; 18(1):19-23. PubMed ID: 7520058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.